Glucuronidation of trans-resveratrol by human liver and intestinal microsomes and UGT isoforms

Journal of Pharmacy and Pharmacology

Volumn 58, Issue 4, 2006, Pages 469-479

  Brill, Shirley S ^a   Furimsky, Anna M ^a   Ho, Mark N ^a   Furniss, Michael J ^a   Li, Yi ^a   Green, Adam G ^a   Bradford, Wallace W ^a   Green, Carol E ^a   Kapetanovic, Izet M ^b   Iyer, Lalitha V ^a  

^a SRI INTERNATIONAL   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; 7 ETHYL 10 HYDROXYCAMPTOTHECIN GLUCURONIDE; 7 HYDROXYTRIFLUOROMETHYLCOUMARIN; BILIRUBIN; CARBON 14; COMPLEMENTARY DNA; COUMARIN DERIVATIVE; GLUCURONOSYLTRANSFERASE; PHYTOESTROGEN; RESVERATROL; STILBENE DERIVATIVE; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE GLUCURONIC ACID;

ARTICLE; BIOAVAILABILITY; CHEMICAL STRUCTURE; CONTROLLED STUDY; ENZYME SUBSTRATE; GLUCURONIDATION; HUMAN; HUMAN TISSUE; INTESTINE; ISOTOPE LABELING; LIVER; LIVER MICROSOME; RED WINE; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCURONIDES; GLUCURONOSYLTRANSFERASE; HUMANS; INSECTS; ISOENZYMES; MICROSOMES, LIVER; STILBENES;

EID: 33645568250     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.58.4.0006     Document Type: Article

References (60)

1. Aggarwal, B. B., Bhardwaj, A., Aggarwal, R. S., Seeram, N. P., Shishodia, S., Takada, Y. (2004) Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res. 24: 2783-2840
2. Aumont, V., Krisa, S., Battaglia, E., Netter, P., Richard, T., Merillon, J. M., Magdalou, J., Sabolovic, N. (2001) Regioselective and stereospecific glucuronidation of trans- and cis- resveratrol in human. Arch. Biochem. Biophys. 393: 281-289
3. Aziz, M. H., Kumar, R., Ahmad, N. (2003) Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms (review). Int. J. Oncol. 23: 17-28
4. Boersma, M. G., van der Woude, H., Bogaards, J., Boeren, S., Vervoort, J., Cnubben, N. H., van Iersel, M. L., van Bladeren, P. J., Rietjens, I. M. (2002) Regioselectivity of phase II metabolism of luteolin and quercetin by UDP-glucuronosyl transferases. Chem. Res. Toxicol. 15: 662-670
5. Bosma, P. J., Seppen, J., Goldhoorn, B., Bakker, C., Oude Elferink, R. P., Chowdhury, J. R., Chowdhury, N. R., Jansen, P. L. (1994) Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man. J. Biol. Chem. 269: 17960-17964
6. Bosma, P. J., Chowdhury, J. R., Bakker, C., Gantla, S., Boer, A., Oostra, B. A. (1995) The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N. Engl. J. Med. 333: 1171-1175
7. Chang, T. K., Chen, J., Lee, W. B. (2001) Differential inhibition and inactivation of human CYP1 enzymes by trans-resveratrol: evidence for mechanism-based inactivation of CYP1A2. J. Pharmacol. Exp. Ther. 299: 874-882
8. Ciolino, H. P., Yeh, G. C. (1999) Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol. Mol. Pharmacol. 56: 760-767
9. Court, M. H., Duan, S. X., von Moltke, L. L., Greenblatt, D. J., Patten, C. J., Miners, J. O., Mackenzie, P. I. (2001) Interindividual variability in acetaminophen glucuronidation by human liver microsomes: identification of relevant acetaminophen UDP-glucuronosyltransferase isoforms. J. Pharmacol. Exp. Ther. 299: 998-1006
10. Court, M. H., Duan, S. X., Guillemette, C., Journault, K., Krishnaswamy, S., Von Moltke, L. L., Greenblatt, D. J. (2002) Stereoselective conjugation of oxazepam by human UDP-glucuronosyltransferases (UGTs): S-oxazepam is glucuronidated by UGT2B15, while R-oxazepam is glucuronidated by UGT2B7 and UGT1A9. Drug Metab. Dispos. 30: 1257-1265
11. Crigler, J. F., Najjar, V. A. (1952) Congenital familial nonhemolytic jaundice with kernicterus. Pediatrics 10: 169-180
12. De Santi, C., Pietrabissa, A., Mosca, F., Pacifici, G. M. (2000a) Glucuronidation of resveratrol, a natural product present in grape and wine, in the human liver. Xenobiotica 30: 1047-1054
13. De Santi, C., Pietrabissa, A., Spisni, R., Mosca, F., Pacifici, G. M. (2000b) Sulphation of resveratrol, a natural compound present in wine, and its inhibition by natural flavonoids. Xenobiotica 30: 857-866
14. De Santi, C., Pietrabissa, A., Spisni, R., Mosca, F., Pacifici, G. M. (2000c) Sulphation of resveratrol, a natural product present in grapes and wine, in the human liver and duodenum. Xenobiotica 30: 609-617
15. Ebner, T., Remmel, R. P., Burchell, B. (1993) Human bilirubin UDP-glucuronosyltransferase catalyzes the glucuronidation of ethinylestradiol. Mol. Pharmacol. 43: 649-654
16. Findlay, K. A., Kaptein, E., Visser, T. J., Burchell, B. (2000) Characterization of the uridine diphosphate-glucuronosyl-transferase-catalyzing thyroid hormone glucuronidation in man. J. Clin. Endocrinol. Metab. 85: 2879-2883
17. Fisher, M. B., Campanale, K., Ackermann, B. L., VandenBranden, M., Wrighton, S. A. (2000) In vitro glucuronidation using human liver microsomes and the pore-forming peptide alamethicin. Drug Metab. Dispos. 28: 560-566
18. Frances, B., Gout, R., Monsarrat, B., Cros, J., Zajac, J. M. (1992) Further evidence that morphine-6 beta-glucuronide is a more potent opioid agonist than morphine. J. Pharmacol. Exp. Ther. 262: 25-31
19. Gescher, A. J., Steward, W. P. (2003) Relationship between mechanisms, bioavailability, and preclinical chemopreventive efficacy of resveratrol: a conundrum. Cancer Epidemiol. Biomarkers Prev. 12: 953-957
20. Girard, H., Court, M. H., Bernard, O., Fortier, L. C., Villeneuve, L., Hao, Q., Greenblatt, D. J., von Moltke, L. L., Perussed, L., Guillemette, C. (2004) Identification of common polymorphisms in the promoter of the UGT1A9 gene: evidence that UGT1A9 protein and activity levels are strongly genetically controlled in the liver. Pharmacogenetics 14: 501-515
21. Guengerich, F. P., Chun, Y. J., Kim, D., Gillam, E. M., Shimada, T. (2003) Cytochrome P450 1B1: a target for inhibition in anticarcinogenesis strategies. Mutat. Res. 523-524: 173-182
22. Hanioka, N., Ozawa, S., Jinno, H., Ando, M., Saito, Y., Sawada, J. (2001) Human liver UDP-glucuronosyltransferase isoforms involved in the glucuronidation of 7-ethyl-10-hydroxycamptothecin. Xenobiotica 31: 687-699
23. Iyer, L., King, C. D., Whitington, P. F., Green, M. D., Roy, S. K., Tephly, T. R., Coffman, B. L., Ratain, M. J. (1998) Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes. J. Clin. Invest. 101: 847-854
24. Iyer, L., Hall, D., Das, S., Mortell, M. A., Ramirez, J., Kim, S., Di Rienzo, A., Ratain, M. J. (1999) Phenotype-genotype correlation of in vitro SN-38 (active metabolite of irinotecan) and bilirubin glucuronidation in human liver tissue with UGT1A1 promoter polymorphism. Clin. Pharmacol. Ther. 65: 576-582
25. Iyer, L., Das, S., Janisch, L., Wen, M., Ramirez, J., Karrison, T., Fleming, G. F., Vokes, E. E., Schilsky, R. L., Ratain, M. J. (2002) UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity. Pharmacogenomics J. 2: 43-47
26. Iyer, L. V., Ho, M. N., Shinn, W. M., Bradford, W. W., Tanga, M. J., Nath, S. S., Green, C. E. (2003) Glucuronidation of 1′-hydroxyestragole (1′-HE) by human UDP-glucuronosyltransferases UGT2B7 and UGT1A9. Toxicol. Sci. 73: 36-43
27. Kaku, T., Ogura, K., Nishiyama, T., Ohnuma, T., Muro, K., Hiratsuka, A. (2004) Quaternary ammonium-linked glucuronidation of tamoxifen by human liver microsomes and UDP-glucuronosyltransferase 1A4. Biochem. Pharmacol. 67: 2093-2102
28. Kaldas, M. I., Walle, U. K., Walle, T. (2003) Resveratrol transport and metabolism by human intestinal Caco-2 cells. J. Pharm. Pharmacol. 55: 307-312
29. Kopp, P. (1998) Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the 'French paradox'? Eur. J. Endocrinol. 138: 619-620
30. Kuhnle, G., Spencer, J. P., Chowrimootoo, G., Schroeter, H., Debnam, E. S., Srai, S. K., Rice-Evans, C., Hahn, U. (2000) Resveratrol is absorbed in the small intestine as resveratrol glucuronide. Biochem. Biophys. Res. Commun. 272: 212-217
31. Learmonth, D. A. (2003) A concise synthesis of the 3-O-beta-D- and 4′-O-beta-D-glucuronide conjugates of trans-resveratrol. Bioconjug. Chem. 14: 262-267
32. Leonard, S. S., Xia, C., Jiang, B. H., Stinefelt, B., Klandorf, H., Harris, G. K., Shi, X. (2003) Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses. Biochem. Biophys. Res. Commun. 309: 1017-1026
33. Li, Z. G., Hong, T., Shimada, Y., Komoto, I., Kawabe, A., Ding, Y., Kaganoi, J., Hashimoto, Y., Imamura, M. (2002) Suppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by resveratrol. Carcinogenesis 23: 1531-1536
34. Li, Y., Shin, Y. G., Yu, C., Kosmeder, J. W., Hirschelman, W. H., Pezzuto, J. M., van Breemen, R. B. (2003) Increasing the throughput and productivity of Caco-2 cell permeability assays using liquid chromatography-mass spectrometry: application to resveratrol absorption and metabolism. Comb. Chem. High Throughput Screen. 6: 757-767
35. Mackenzie, P. I., Owens, I. S., Burchell, B., Bock, K. W., Bairoch, A., Belanger, A., Fournel-Gigleux, S., Green, M., Hum, D. W., Iyanagi, T., Lancet, D., Louisot, P., Magdalou, J., Chowdhury, J. R., Ritter, J. K., Schachter, H., Tephly, T. R., Tipton, K. F., Nebert, D. W. (1997) The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics 7: 255-269
36. Marier, J. F., Vachon, P., Gritsas, A., Zhang, J., Moreau, J. P., Ducharme, M. P. (2002) Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model. J. Pharmacol. Exp. Ther. 302: 369-373
37. Matern, H., Heinemann, H., Matern, S. (1994) Radioassay of UDP-glucuronosyltransferase activities toward endogenous substrates using labeled UDP-glucuronic acid and an organic solvent extraction procedure. Anal. Biochem. 219: 182-188
38. Matsuoka, A., Takeshita, K., Furuta, A., Ozaki, M., Fukuhara, K., Miyata, N. (2002) The 4′-hydroxy group is responsible for the in vitro cytogenetic activity of resveratrol. Mutat. Res. 521: 29-35
39. Miura, D., Miura, Y., Yagasaki, K. (2003) Hypolipidemic action of dietary resveratrol, a phytoalexin in grapes and red wine, in hepatoma-bearing rats. Life Sci. 73: 1393-1400
40. Nath, S. S., Ho, M. N., Furniss, M. J., Sharp, L. E., Green, A. G., Bradford, W. W., Green, C. E., Swezey, R., Kapetanovic, I. M., Iyer, L. V. (2004) In vitro metabolism and drug interaction studies with trans-resveratrol. Drug Metab. Rev. 36: 153 (Abstract)
41. Pezzuto, J. M. (2004) Resveratrol: a whiff that induces a biologically specific tsunami. Cancer Biol. Ther. 3: 889-890
42. Piver, B., Berthou, F., Dreano, Y., Lucas, D. (2001) Inhibition of CYP3A, CYP1A and CYP2E1 activities by resveratrol and other non volatile red wine components. Toxicol. Lett. 125: 83-91
43. Piver, B., Fer, M., Vitrac, X., Merillon, J. M., Dreano, Y., Berthou, F., Lucas, D. (2004) Involvement of cytochrome P450 1A2 in the biotransformation of trans-resveratrol in human liver microsomes. Biochem. Pharmacol. 68: 773-782
44. Potter, G. A., Patterson, L. H., Wanogho, E., Perry, P. J., Butler, P. C., Ijaz, T., Ruparelia, K. C., Lamb, J. H., Farmer, P. B., Stanley, L. A., Burke, M. D. (2002) The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1. Br. J. Cancer 86: 774-778
45. Ramirez, J., Iyer, L., Journault, K., Belanger, P., Innocenti, F., Ratain, M. J., Guillemette, C. (2002) In vitro characterization of hepatic flavopiridol metabolism using human liver microsomes and recombinant UGT enzymes. Pharm. Res. 19: 588-594
46. Rios, G. R., Tephly, T. R. (2002) Inhibition and active sites of UDP-glucuronosyltransferases 2B7 and 1A1. Drug Metab. Dispos. 30: 1364-1367
47. Senafi, S. B., Clarke, D. J., Burchell, B. (1994) Investigation of the substrate specificity of a cloned expressed human bilirubin UDP- glucuronosyltransferase: UDP-sugar specificity and involvement in steroid and xenobiotic glucuronidation. Biochem. J. 303 (Pt 1): 233-240
48. Signorelli, P., Ghidoni, R. (2005) Resveratrol as an anticancer nutrient: molecular basis, open questions and promises. J. Nutr. Biochem. 16: 449-466
49. Strassburg, C. P., Oldhafer, K., Manns, M. P., Tukey, R. H. (1997) Differential expression of the UGT1A locus in human liver, biliary, and gastric tissue: identification of UGT1A7 and UGT1A10 transcripts in extrahepatic tissue. Mol. Pharmacol. 52: 212-220
50. Strassburg, C. P., Manns, M. P., Tukey, R. H. (1998) Expression of the UDP-glucuronosyltransferase 1A locus in human colon. Identification and characterization of the novel extrahepatic UGT1A8. J. Biol. Chem. 273: 8719-8726
51. Tallman, M. N., Ritter, J. K., Smith, P. C. (2005) Differential rates of glucuronidation for 7-ethyl-10-hydroxy-camptothecin (SN-38) lactone and carboxylate in human and rat microsomes and recombinant UDP- glucuronosyltransferase isoforms. Drug Metab. Dispos. 33: 977-983
52. Tessitore, L., Davit, A., Sarotto, I., Caderni, G. (2000) Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21(CIP) expression. Carcinogenesis 21: 1619-1622
53. Thakkar, K., Geahlen, R. L., Cushman, M. (1993) Synthesis and protein-tyrosine kinase inhibitory activity of polyhydroxylated stilbene analogues of piceatannol. J. Med. Chem. 36: 2950-2955
54. Walle, T., Hsieh, F., DeLegge, M. H., Oatis, J. E., Jr., Walle, U. K. (2004) High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab. Dispos. 32: 1377-1382
55. Watanabe, Y., Nakajima, M., Ohashi, N., Kume, T., Yokoi, T. (2003) Glucuronidation of etoposide in human liver microsomes is specifically catalyzed by UDP-glucuronosyltransferase 1A1. Drug Metab. Dispos. 31: 589-595
56. Wenzel, E., Somoza, V. (2005) Metabolism and bioavailability of trans-resveratrol. Mol. Nutr. Food Res. 49: 472-481
57. Wenzel, E., Soldo, T., Erbersdobler, H., Somoza, V. (2005) Bioactivity and metabolism of trans-resveratrol orally administered to Wistar rats. Mol. Nutr. Food Res. 49: 482-494
58. Yamanaka, H., Nakajima, M., Katoh, M., Hara, Y., Tachibana, O., Yamashita, J., McLeod, H. L., Yokoi, T. (2004) A novel polymorphism in the promoter region of human UGT1A9 gene (UGT1A9*22) and its effects on the transcriptional activity. Pharmacogenetics 14: 329-332
59. Yu, C., Shin, Y. G., Kosmeder, J. W., Pezzuto, J. M., van Breemen, R. B. (2003) Liquid chromatography/tandem mass spectrometric determination of inhibition of human cytochrome P450 isozymes by resveratrol and resveratrol-3-sulfate. Rapid Commun. Mass Spectrom. 17: 307-313
60. Zern, T. L., West, K. L., Fernandez, M. L. (2003) Grape polyphenols decrease plasma triglycerides and cholesterol accumulation in the aorta of ovariectomized guinea pigs. J. Nutr. 133: 2268-2272